Core Insights - Medidata has launched the Medidata Data Experience, which includes Health Record Connect and Rave Companion, aimed at expediting the development of life-saving medicines for patients by integrating electronic health records (EHR) into clinical trials [1][2] Group 1: Medidata Data Experience - The Medidata Data Experience will be available to select National Cancer Institute (NCI) Lead Protocol Organizations (LPO), facilitating the automatic elevation of patient data from EHR systems into the Medidata Platform [1] - The integration of Health Record Connect and Rave Companion is expected to reduce administrative burdens, enhance insights, and allow clinical sites to focus more on patient care [1][2] Group 2: Benefits of the New Solutions - The new solutions aim to solve the industry's long-standing challenge of using EHR in clinical studies, enabling NCI LPOs to input data up to 90% faster [2] - By minimizing duplicative tasks for research sites, the technology is designed to accelerate timelines and improve overall data quality, enhancing the experience for both researchers and patients [2] Group 3: Medidata's Experience and Impact - Medidata has supported the NCI Cancer Therapy Evaluation Program (CTEP) for 17 years, reinforcing NCI's ability to manage clinical operations effectively [3] - The company has a strong track record, having powered over 36,000 trials and served 11 million patients, showcasing its expertise and extensive clinical trial data set [4]

Core Insights - Medidata Clinical Data Studio has supported 465 global studies since its launch in 2024, significantly reducing data review cycles by up to 80% and accelerating patient profile reviews by 50% [1] - The solution has gained traction among major biopharmaceutical companies and contract research organizations, enhancing data review, trial oversight, and operational efficiency [1][2] Company Overview - Medidata, a brand of Dassault Systèmes, has been a leader in providing clinical trial solutions for 25 years, supporting over 36,000 trials and 11 million patients [5] - The company has more than 1 million registered users across approximately 2,300 customers, emphasizing its extensive reach and trust within the industry [5] Industry Context - As clinical trials become more complex, life sciences organizations are increasingly pressured to unify their data and analytics strategies for better decision-making [2] - Medidata Clinical Data Studio is positioned as a next-generation platform that integrates AI, advanced analytics, and domain expertise to enhance the drug development lifecycle [2] Recognition and Awards - Clinical Data Studio has received multiple industry awards, including the SCOPE Best of Show Award, the CUBE Technology Innovation Award, and the Pharmaceutical Excellence Award, highlighting its leadership in intelligent data management [3]